Stocks Health care SILO
NASDAQ · Health careSilo Pharma, Inc. (SILO)
It posted a net loss of $4.5M. At June 30, 2026 it held $3.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Silo Pharma, Inc.
- Net worth
- Silo Pharma, Inc. has a market value (market cap) of $2.9M at the latest share price, and shareholders' equity of $4.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $72.1K (0.0% year on year), with a net loss of $4.2M.
- Cash flow
- In fiscal 2025 operations used $4.7M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Silo Pharma, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Silo Pharma, Inc. does
Silo Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SILO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $72.1K | -$4.2M | -$0.50 | n/a |
| 2024 | $72.1K | -$4.4M | -$1.19 | n/a |
| 2023 | $72.1K | -$3.7M | -$1.20 | n/a |
| 2022 | $72.1K | -$3.9M | n/a | n/a |
| 2021 | n/a | $3.9M | $0.04 | n/a |
| 2020 | $40.9K | -$3M | -$0.05 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SILO ranks in Health care
Latest SEC filings
What Silo Pharma, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 2, 2026Material agreement8-KSilo Pharma acquired software and intellectual property assets from Norsight Consulting in exchange for stock purchase warrants.
- August 19, 2026
- August 17, 2026
- August 13, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 31, 2026
- July 24, 2026
- July 13, 2026
- July 8, 2026Passive stake (5% or more) SCHEDULE 13G
- June 30, 2026
Insider trades
What the people running Silo Pharma, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| December 15, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 2,500 | $1K |
| December 15, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 2,500 | $1.1K |
| November 21, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 1,000 | $365 |
| November 20, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 1,000 | $370 |
| November 19, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 4,500 | $1.8K |
| November 18, 2025 | Weisblum EricChief Executive Officer, Director | Bought | 7,500 | $3K |
Who owns SILO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mitchell P. Kopin13G, passive with 2 related filers | 9.99% | August 13, 2026 |
| AdvisorShares Trust13G, passive | 6.69% | July 8, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 216,932 shares in total, about $397K at the last price.
| Holder | Shares |
|---|---|
| Weisblum EricChief Executive Officer, Director | 216,932 |
Questions about SILO
What does Silo Pharma, Inc. do?
Silo Pharma, Inc. is a company in the Health care sector, listed on NASDAQ as SILO. Its shares trade on NASDAQ under the ticker SILO.
What is Silo Pharma, Inc.'s net worth?
Silo Pharma, Inc. has a market value (market cap) of $2.9M at the latest share price, and shareholders' equity of $4.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Silo Pharma, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $4.5M.
When did Silo Pharma, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from October 2, 2026.
When is Silo Pharma, Inc.'s next earnings report?
Silo Pharma, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare SILO with
Follow SILO
Get an email when Silo Pharma, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Silo Pharma, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.